Profilo
Mr. Michael Mullette is a Chief Commercial Officer at Vaxcyte, Inc. Mr. Mullette was previously employed as a Chief Executive & Operating Officer by Lykos Therapeutics, Inc. and a Managing Director-Canada by Moderna, Inc. He received his undergraduate degree from Villanova University and an MBA from Lehigh University.
Posizioni attive di Michael Mullette
| Società | Posizione | Inizio |
|---|---|---|
| VAXCYTE, INC. | Corporate Officer/Principal | - |
Precedenti posizioni note di Michael Mullette
| Società | Posizione | Fine |
|---|---|---|
Lykos Therapeutics PBC
Lykos Therapeutics PBC BiotechnologyHealth Technology Engages in healing and well-being through psychedelic drug development & therapist training programs | Amministratore Delegato | 01/11/2025 |
| MODERNA, INC. | Corporate Officer/Principal | - |
Formazione di Michael Mullette
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Lehigh University
Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vaxcyte, Inc.
Vaxcyte, Inc. BiotechnologyHealth Technology Develops vaccines for infectious diseases | Health Technology |
Moderna, Inc.
Moderna, Inc. BiotechnologyHealth Technology Researches, develops, manufactures and commercializes mRNA-based respiratory & other virus vaccines, oncology and rare disease therapeutics | Health Technology |
Lykos Therapeutics PBC
Lykos Therapeutics PBC BiotechnologyHealth Technology Engages in healing and well-being through psychedelic drug development & therapist training programs | Health Technology |
















